Document is current
Any future updates will be listed below
-
Authors
van den Ende, Nadine S. https://orcid.org/0000-0002-6906-4876
Smid, Marcel
Martens, John W. M.
Debets, Reno
Jager, Agnes
van Deurzen, Carolien H. M.
-
Funding
Funding for this research was provided by:
ZonMw
- License Information
-
More Information
Article History
Received: 27 November 2025
Accepted: 1 May 2026
First Online: 13 May 2026
Competing interests
: Roche delivered the materials for DNA isolation and sequencing; however, this did not have any influence on the substantive matters within this article. C.H.M. van Deurzen has received research funding from AstraZeneca, which was unrelated to this project. R. Debets received research support from MSD and Bayer, personal fees from Bluebird Bio, Genticel, other support from Pan Cancer T, which was unrelated to the submitted work (all paid to the Erasmus MC Cancer Institute), as well as European patent application nos. 21152822.9, 24192717.7, and 25163944.9 (pending to Erasmus MC). J.W.M. Martens received research funding from Menarini, Tzu genomics, MSD, and Pfizer, and a consultancy fee from Novartis; these were all unrelated to this project. All the other authors declare no potential competing interests.
